Stonvex publishes market data and research only. Not investment advice. Not a registered investment advisor. Read disclaimer.

CLLS

Live52w high -28.5%

Core line items from CLLS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.

Entity: CELLECTIS S.A.·Source: SEC EDGAR companyfacts

Metric	Annual 2025 2025-12-31	Annual 2024 2024-12-31	Annual 2023 2023-12-31	Annual 2022 2022-12-31
Revenue	$72.95M	$41.51M	$755.00K	$19.17M
Operating Income	$-33.08M	$-59.55M	$-97.30M	$-89.67M
Net Income	$-67.59M	$-36.76M	$-108.44M	$-114.03M
EPS (Diluted)	$-0.67	$-0.41	$-1.77	$-2.33
Total Assets	$324.72M	$383.54M	$334.27M	$261.22M
Total Liabilities	$248.82M	$252.51M	$249.57M	Not available
Cash & Equivalents	$61.53M	$143.25M	$136.71M	$93.22M
Free Cash Flow OCF − CapEx	$-41.76M	$20.41M	$-25.82M	$-89.88M
Shares Outstanding	100.34M	100.09M	71.75M	45.68M

Financial data is sourced from public SEC filings where available. Some metrics may be unavailable without premium market data.

Core line items from CLLS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.

52w high -28.5%

Entity: CELLECTIS S.A.·Source: SEC EDGAR companyfacts

Metric	Annual 2025 2025-12-31	Annual 2024 2024-12-31	Annual 2023 2023-12-31	Annual 2022 2022-12-31
Revenue	$72.95M	$41.51M	$755.00K	$19.17M
Operating Income	$-33.08M	$-59.55M	$-97.30M	$-89.67M
Net Income	$-67.59M	$-36.76M	$-108.44M	$-114.03M
EPS (Diluted)	$-0.67	$-0.41	$-1.77	$-2.33
Total Assets	$324.72M	$383.54M	$334.27M	$261.22M
Total Liabilities	$248.82M	$252.51M	$249.57M	Not available
Cash & Equivalents	$61.53M	$143.25M	$136.71M	$93.22M
Free Cash Flow OCF − CapEx	$-41.76M	$20.41M	$-25.82M	$-89.88M
Shares Outstanding	100.34M	100.09M	71.75M	45.68M

Financial data is sourced from public SEC filings where available. Some metrics may be unavailable without premium market data.